The Endothelial Glycocalyx and Neonatal Sepsis
Open Access
- 26 December 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (1) , 364
Abstract
Sepsis carries a substantial risk of morbidity and mortality in newborns, especially preterm-born neonates. Endothelial glycocalyx (eGC) is a carbohydrate-rich layer lining the vascular endothelium, with important vascular barrier function and cell adhesion properties, serving also as a mechano-sensor for blood flow. eGC shedding is recognized as a fundamental pathophysiological process generating microvascular dysfunction, which in turn contributes to multiple organ failure and death in sepsis. Although the disruption of eGC and its consequences have been investigated intensively in the adult population, its composition, development, and potential mechanisms of action are still poorly studied during the neonatal period, and more specifically, in neonatal sepsis. Further knowledge on this topic may provide a better understanding of the molecular mechanisms that guide the sepsis pathology during the neonatal period, and would increase the usefulness of endothelial glycocalyx dysfunction as a diagnostic and prognostic biomarker. We reviewed several components of the eGC that help to deeply understand the mechanisms involved in the eGC disruption during the neonatal period. In addition, we evaluated the potential of eGC components as biomarkers and future targets to develop therapeutic strategies for neonatal sepsis.Keywords
Funding Information
- Spanish Institute of Health Carlos III (AES2019, PI19/00994, PN 2018-2021, RD16/0022, ACCI2018-09, AP174352020)
- European Regional Development Fund (ERDF) (AES2019, PI19/00994, PN 2018-2021, RD16/0022, ACCI2018-09, AP174352020)
- ISCIII- Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (FEDER) (AES2019, PI19/00994, PN 2018-2021, RD16/0022, ACCI2018-09, AP174352020)
- Spanish Institute of Health Carlos III through CIBERer (Biomedical Network Research Center on Rare Diseases) (AES2019, PI19/00994, PN 2018-2021, RD16/0022, ACCI2018-09, AP174352020)
- Fundación Mutua Madrileña (AES2019, PI19/00994, PN 2018-2021, RD16/0022, ACCI2018-09, AP174352020)
This publication has 133 references indexed in Scilit:
- Quantification of the endothelial surface glycocalyx on rat and mouse blood vesselsMicrovascular Research, 2012
- Heparan Sulfate Chains of Syndecan-1 Regulate Ectodomain SheddingJournal of Biological Chemistry, 2012
- A novel role for matrix metalloproteinase-8 in sepsis*Critical Care Medicine, 2012
- Inter-Alpha Inhibitor Protein Level in Neonates Predicts Necrotizing EnterocolitisThe Journal of Pediatrics, 2010
- Inter-Alpha Inhibitor Protein Administration Improves Survival From Neonatal Sepsis in MicePediatric Research, 2010
- Proinflammatory Cytokines Induce Hyaluronan Synthesis and Monocyte Adhesion in Human Endothelial Cells through Hyaluronan Synthase 2 (HAS2) and the Nuclear Factor-κB (NF-κB) PathwayJournal of Biological Chemistry, 2010
- A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trialArchives of Disease in Childhood - Fetal and Neonatal Edition, 2010
- Pathophysiology and Treatment of Septic Shock in NeonatesClinics in Perinatology, 2010
- INCREASED LEVELS OF GLYCOSAMINOGLYCANS DURING SEPTIC SHOCKShock, 2008
- The endothelial glycocalyx: composition, functions, and visualizationPflügers Archiv - European Journal of Physiology, 2007